ABCL Financials
Abcellera Biologics Inc - Financial statements & key metrics
Stock Price
$4.16
Market Cap
$1.23B
EPS
$-0.57
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$28.83M
Gross Profit
-
Operating Income
-
Net Income
$-162.86M
EPS (Diluted)
$-0.55
Balance Sheet Highlights
Total Assets
$1.36B
Total Liabilities
$304.47M
Shareholders Equity
-
Cash & Equivalents
$127.10M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-108.56M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-417.5%
Operating Margin
-8.5%
ROE
-0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ABCL revenue?
ABCL's most recent quarterly revenue was $28.83M. Annual revenue can be calculated by summing the four most recent quarters.
Is ABCL profitable?
ABCL reported a loss of $162.86M in the most recent quarter.
What is ABCL market cap?
ABCL has a market capitalization of $1.23B, making it a small-cap stock.
Does ABCL have debt?
View ABCL's balance sheet for debt information.
What is ABCL cash flow?
Cash flow data is available in the full financial statements.